Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Neuropilin 1 ELISA Kit (AC3954)
Cat.#: ASET-2543
Specifications
Description Human Neuropilin 1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Neuropilin 1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.054 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 1.5-24 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2490 Human PSPN ELISA Kit (AC3901) Quantitative inquiry ASET-2180 Rat alpha 2a Adrenergic Receptor ELISA Kit (AC3591) Quantitative inquiry ASET-1150 Mouse Galectin 3 ELISA Kit (AC2561) Quantitative inquiry ASET-1178 Mouse LRRK2 ELISA Kit (AC2589) Quantitative inquiry ASET-1715 Mouse CaMKII beta ELISA Kit (AC3126) Quantitative inquiry ASET-2166 Human VGF ELISA Kit (AC3577) Quantitative inquiry ASET-1434 Rat Rabphilin 3A ELISA Kit (AC2845) Quantitative inquiry ASET-1163 Human Ephrin B1 ELISA Kit (AC2574) Quantitative inquiry ASET-1373 Human Laminin 2 alpha ELISA Kit (AC2784) Quantitative inquiry ASET-1604 Rabbit IL-6 ELISA Kit (AC3015) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket